ramp care tirzepatide Big update in pediatric diabetes 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ How long does it take

Keep your titration schedule so you always have medication

User-Friendly Technology The best programs leverage technology to enhance the user experience

Novo Nordisk has launched its own telehealth programme for regular-dose semaglutide through its own channels, as well as other providers, for $499 per month, although a partnership with Hims & Hers quickly broke down due to what the company said were "concerns about [] illegal mass compounding and deceptive marketing." Hims & Hers which accused Novo Nordisk of 'anticompetitive' actions is now offering a compounded version at $199 per month.

Clinical trial data and real-world reports suggest headache incidence varies significantly between individuals, suggesting that baseline health status and metabolic factors play a role in symptom presentation